Načítá se...
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
The development of CFTR modulator therapies significantly changed the treatment scheme of people with cystic fibrosis. However, CFTR modulator therapy is still a life-long treatment, which is not able to correct the genetic defect and cure the disease. Therefore, it becomes crucial to understand the...
Uloženo v:
| Vydáno v: | Front Cell Infect Microbiol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8010178/ https://ncbi.nlm.nih.gov/pubmed/33816324 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2021.548613 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|